Ironwood Pharmaceuticals Inc
- Bearish sentiment is moderate and increasing
- Economic output in this company's sector is expanding
Short interest | Negative
Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on April 9.
ETF/Index ownership | Neutral
ETF activity is neutral. The net inflows of $3.08 billion over the last one-month into ETFs that hold IRWD are not among the highest of the last year and have been slowing.
PMI by IHS Markit | Positive
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating.
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to firstname.lastname@example.org.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.